ArticleJournal of neuro-oncology2024

Treatment outcome of IDH1/2 wildtype CNS WHO grade 4 glioma histologically diagnosed as WHO grade II or III astrocytomas.

Naureen Keric et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.